Advertisement

IOF Regional 7th Asia-Pacific Osteoporosis Conference Sydney, Australia 2018 – Meet-the-Expert Sessions Abstracts

Abstract
  • 16 Downloads

MTE1

RECENT FRACTURE: WHEN AND HOW TO TREAT OSTEOPOROSIS

J. K. Lee1,2

1Beacon International Specialist Centre, Petaling Jaya, Malaysia, 2Advanced Neuroscience & Orthopaedic Centre (ANOC), Kuala Lumpur, Malaysia

The dilemma in clinical practice is when to initiate treatment following an osteoporosis related fracture. There are concerns whether early treatment with antiresorptive agents in particular bisphosphonates may impair fracture healing. This is one of the main reasons why patients with fragility fractures do not receive appropriate pharmacological treatments following their fractures. Low treatment rate, poor compliance and adherence lead on to increase incidence of subsequent fractures.

Bisphosphonates are commonly used to treat osteoporosis in clinical practice. The potent antiresorptive agents suppress bone turnover therefore improve bone density and bone quality. However, the concern of using such potent antiresorptive in clinical practice is over suppression of bone turnover...

Copyright information

© International Osteoporosis Foundation and National Osteoporosis Foundation 2019

Personalised recommendations